IRIS
SARACENO, GIOVANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 632
EU - Europa 569
AS - Asia 188
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.393
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 632
IE - Irlanda 193
SE - Svezia 176
CN - Cina 150
DE - Germania 38
IT - Italia 32
FI - Finlandia 28
GB - Regno Unito 21
UA - Ucraina 20
SG - Singapore 17
IN - India 16
AT - Austria 14
PL - Polonia 13
CH - Svizzera 10
FR - Francia 7
CZ - Repubblica Ceca 6
ES - Italia 5
BE - Belgio 3
KR - Corea 2
NL - Olanda 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
PH - Filippine 1
RU - Federazione Russa 1
Totale 1.393
Salva come PNG Salva come JPEG
Città #
Dublin 193
Chandler 123
Nyköping 107
Jacksonville 67
Beijing 48
New York 42
Ashburn 39
Dearborn 31
Princeton 29
Cambridge 27
Des Moines 24
Medford 20
Ann Arbor 15
Jinan 15
Lancaster 14
Mountain View 14
Bad Aussee 13
Boardman 13
Nanjing 13
Woodbridge 12
Ningbo 11
Shenyang 10
Warsaw 10
Singapore 9
Munich 8
San Mateo 8
Tianjin 8
Wilmington 7
Brno 6
Cosenza 5
Hyderabad 5
Jiaxing 5
Messina 5
Seattle 5
Bremen 4
Fuzhou 4
Hebei 4
Pune 4
Taizhou 4
Zhengzhou 4
Aci Castello 3
Brussels 3
Changsha 3
Chennai 3
Guangzhou 3
Nanchang 3
Taiyuan 3
la Garriga 3
Dallas 2
Dong Ket 2
East Brunswick 2
Haikou 2
Hangzhou 2
Houston 2
Lodz 2
Mumbai 2
Norwalk 2
Pittsburgh 2
Sabadell 2
San Antonio 2
Seongnam-si 2
Solon 2
Albany 1
Amstelveen 1
Angeles City 1
Bengaluru 1
Cagliari 1
Changle 1
Chicago 1
Darmstadt 1
Helsinki 1
Kemerovo 1
L'hay-les-roses 1
London 1
Lublin 1
Milan 1
Napoli 1
Nürnberg 1
Qingdao 1
Quito 1
Redwood City 1
Riva 1
Rome 1
Saint Paul 1
San Gregorio 1
Washington 1
Totale 1.061
Salva come PNG Salva come JPEG
Nome #
Coffee impairs intestinal absoprtion of levo-thyroxine: report of additional cases. 88
Additional cases of impairment of L-thyroxine (L-T4) intestinal absorption caused by coffee. 74
A minimum of two years of undertreated primary hypothyroidism, as a result of drug-induced malabsorption of L-thyroxine, may have metabolic and cardiovascular consequences 74
Coffee Impairs Intestinal Absorbtion of Levothyroxine: Report of Additional Cases 69
A novel formulation of L-thyroxine (L-T4) solves problems of L-T4 malabsorption caused by coffee in patients under replacement or TSH suppressive L-T4 therapy with conventional tablets. 67
A liquid formulation of L-thyroxine (L-T4) solves problems of incomplete normalization/suppression of serum TSH caused by proton pump inhibitors (PPI) on conventional tablet formulations of L-T4. 64
Altered intestinal absorption of L-thyroxine caused by coffee. 63
Interference of L-T4 absorption by proton-pump inhibitors (PPIs) can be solved by a liquid ormulation of L-thyroxine (L-T4). 63
Ricerca della mutazione BRAF V600E su citoaspirato ecoguidato dei noduli tiroidei in pazienti dell'area dello Stretto. 62
FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA PRESENTING AS A TOXIC NODULE IN AN ADOLESCENT GIRL 55
BIOINFORMATICS SUPPORT THE POSSIBLE TRIGGERING OF AUTOIMMUNE THYROID DISEASES BY YERSINIA ENTEROCOLITICA OUTER MEMBRANE PROTEINS HOMOLOGOUS TO THE HUMAN TSH RECEPTOR 53
In patients with no interference on the intestinal absorption of L-T4 caused by gastro-intestinal disorders or drugs, a liquid formulation of L-T4 permits to reach target TSH levels that were missed by the conventional tablet formulation. 52
Dati bioinformatici a supporto del possibile scatenamento di malattie autoimmuni tiroidee (MAIT) da parte di "outer membrane proteins" (OMP) di Yesrinia enterocolitica (Ye) aventi omologia di sequenza col recettor eumano del TSH (TSHR). 50
Two novel formulations of L-T4 (oral solution and soft gel capsule) are refractory to the coffee-induced intestinal malabsorption of tablet LT4. 48
Una nuova formulazione di L-T4 risolve il problema del malassorbimento intestinale da caffè della L-T4. 46
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 46
Urticaria and thyroid autoimmunity 46
L'interferenza dell'assorbimento della L-tiroxina (L-T4) da parte degli inibitori di pompa protonica (PPI) può essere risolta da una formulazione liquida di L-T4. 45
A novel formulation of l-thyroxine (l-T4) reduces the problem of l-T4 malabsorption by coffee observed with traditional tablet formulations 45
Switching Levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of Levothyroxine induced by proton-pump inhibitors. 40
Dati bioinformatici a supporto del possibile scatenamento di malattie autoimmuni tiroidee da parte di “outer membrane proteins”di Yersinia enterocolitica aventi omologia di sequenza col recettore umano del TSH. 40
Intranuclear cytoplasmic inclusions in cytologically suspicious or malignant thyroid nodules: identification and correlation with echogenicity and size of the nodules. 40
FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA PRESENTING AS A TOXIC NODULE IN AN ADOLESCENT GIRL. 39
Intranuclear cytoplasmic inclusions in cytologically suspicious or malignant nodules: correlation with echo texture and size of the nodules. 38
New targeted therapies for anaplastic thyroid cancer. 33
Increased CXCL9 Serum Levels in Hepatitis C-Related Mixed Cryoglobulinemia, with Autoimmune Thyroiditis, Associated with High Levels of CXCL10 28
Refractoriness of two novel formulations of L-T4 (oral solution and soft gel capsule) to the coffee-induced intestinal absorption of tablet L-T4. 27
Occult leydig cell tumour and androgen-receptor positive breast cancer in a woman with severe hyperandrogenism. 22
Totale 1.417
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.353
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.353
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020174 13 4 0 7 1 32 19 29 2 35 31 1
2020/2021132 10 0 38 9 18 16 4 6 2 8 12 9
2021/2022213 0 29 2 13 10 0 39 6 1 23 36 54
2022/2023518 51 53 22 28 35 56 3 36 220 1 10 3
2023/2024193 12 16 30 8 22 63 0 7 0 9 3 23
2024/202514 14 0 0 0 0 0 0 0 0 0 0 0
Totale 1.417